Australia's Therapeutic Goods Administration has approved the prescription of MDMA and psilocybin by authorized psychiatrists for PTSD and treatment-resistant depression. This decision, a first worldwide, has sparked a debate among experts. While some hail it as a breakthrough for patients unresponsive to conventional therapies, others express concerns about its implementation.
from Neuroscience News https://ift.tt/bFzXvfl
from Neuroscience News https://ift.tt/bFzXvfl
Comments
Post a Comment